<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>16</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>25</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Anti-inflammatory Effects of Novel Thiazolidinone Derivatives as Bioactive Heterocycles on RAW264.7 Cells</title>
    <FirstPage>28</FirstPage>
    <LastPage>38</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Ghafoori</LastName>
        <affiliation locale="en_US">Department of Biology, University of Guilan, Rasht, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrnaz</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Department of Biology, University of Guilan, University Campus 2, Rasht, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Asadollah</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">Department of Chemistry, University of Guilan, Rasht, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>05</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>09</Month>
        <Day>04</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The inhibition of the inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2) and nuclear factor-&#x3BA;B (NF-&#x3BA;B) production are research targets of attract in the field of anti-inflammatory drug development. Therefore, this study&#xA0;was designed to investigate the&#xA0;anti-inflammatory effects of novel thiazolidinone derivatives using a cellular model of lipopolysaccharide (LPS)-stimulated murine macrophage RAW 264.7. In the present study,&#xA0;five&#xA0;new&#xA0;derivatives&#xA0;(A to E) of thiazolidinone were synthesized and screened for anti-inflammatory activities. Cell viability of LPS-stimulated RAW 264.7 macrophages clearly decreased in &gt;55 &#x3BC;g/mL of synthesized A-E compounds especially in the presence of C; therefore, up to 50 &#x3BC;g/mL of compounds were selected for the subsequent analysis. A majority of these compounds showed significant inhibition on the production of NO in LPS-stimulated macrophages in a dose-dependent manner. Compounds B and D (10-50 &#x3BC;g/mL) significantly inhibited LPS-induced NF-&#x3BA;B (p65) production in a dose-dependent manner. The effects of B and D on iNOS and COX-2 mRNA and protein expression in LPS-stimulated RAW 264.7 cells were detected by real time-PCR and western blot. B derivative significantly suppressed the iNOS and COX-2 mRNA level and as well as protein expression. Taken together, these results reveal that compound B as new thiazolidinone derivative decreased expression of the inflammatory-related signals (NO, iNOS and COX-2) through regulation of NF-&#x3BA;B; hence, this compound could be suggested as a novel therapeutic strategy for inflammation-associated disorders.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/907</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/907/705</pdf_url>
  </Article>
</Articles>
